ArticleEuropean journal of applied physiology2026
Influence of age on walking performance among adults with bilateral spastic cerebral palsy.
Article in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Influence of age on walking performance among adults with bilateral spastic cerebral palsy.European journal of applied physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine age-related differences in walking performance and its physiological determinants in adults with bilateral spastic cerebral palsy (CP) compared with typically developed (TD) peers.
methodsThirty adults aged 18-50 years were included: younger (18-25 years; CP
resultsVO₂peak did not differ between groups. However, CP
conclusionOlder adults with CP exhibit pronounced impairments in walking performance despite preserved aerobic capacity. These alterations are associated with increased walking cost, reduced strength, and impaired balance, suggesting accelerated mobility decline in adults with CP. Targeting neuromuscular function and walking economy may therefore represent key strategies to mitigate functional decline in adults with CP.
Indexed as
Identifiers
42287390What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.